COMP <GO>
LNTH vs UNH // FREE CASH FLOW YIELD
Lantheus Holdings Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: LNTH 5
— UNH 8
▲ FREE CASH FLOW YIELD LEADER: UNH
LAST: $100.31 (-0.15%) • MKT CAP: $6.55B
fcf-yield
4.90%
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
fcf-yield
6.25%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LNTH VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LNTH | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 61.10% | 88.31% | -27.21 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.30% | 12.38% | +7.92 | LNTH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.0x | 15.3x | +2.73 | UNH | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 4.90% | 6.25% | -1.35 | UNH | /fcf-yield <GO> |
| Operating Margin | 20.20% | 5.32% | +14.88 | LNTH | /operating-margins <GO> |
| Net Profit Margin | 15.20% | 3.53% | +11.67 | LNTH | /net-margins <GO> |
| Revenue Growth (YoY) | 0.50% | 3.33% | -2.83 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.34 | 3.09 | +2.25 | LNTH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.3 | 55.1 | -2.80 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 0.33 | +0.55 | LNTH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.0x | 17.7x | +8.26 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.55B | $359.43B | -$352.89B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LNTH REV | UNH REV | LNTH GROSS % | UNH GROSS % | LNTH FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.54B | $447.57B | 61.1% | 88.7% | $320.8M | $16.07B |
| FY 2024 | $1.53B | $400.28B | 64.4% | 88.3% | $475.7M | $20.70B |
| FY 2023 | $1.30B | $371.62B | — | 89.6% | $246.9M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LNTH // BETA 0.88
UNH // BETA 0.33